Cardiovascular effects of biological versus conventional synthetic disease-modifying antirheumatic drug therapy in treatment-naïve, early rheumatoid arthritis.
Sven PleinBara ErhayiemGraham FentSarah HortonRaluca Bianca DumitruJacqueline AndrewsJohn P GreenwoodPaul EmeryElizabeth Ma HensorPaul BaxterSue PavittMaya H BuchPublished in: Annals of the rheumatic diseases (2020)
ISRCTN: ISRCTN89222125; ClinicalTrials.gov: NCT01295151.